MAC HYPER REAL SPF 15 FOUNDATION
Dosage form: liquid
Ingredients: OCTINOXATE 7mL in 100mL
Labeler: MAKEUP ART COSMETICS
NDC Code: 40046-0056
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
HYPER REAL SPF 15 FOUNDATION
KEEP OUT OF EYES.
STOP USE IF IRRITATION OCCURS.
KEEP OUT OF REACH OF CHILDREN.
OCTINOXATE 7.00%
WATER (AQUA PURIFICATA) PURIFIED, CYCLOPENTASILOXANE, BUTYLENE GLYCOL, SILICA, DIMETHICONE, PHENYL TRIMETHICONE, BIS-PEG/PPG-14/14 DIMETHICONE, MAGNESIUM SULFATE, TRIMETHYLSILOXYSILICATE, TITANIUM DIOXIDE, TOCOPHERYL ACETATE, RETINYL PALMITATE, ASCORBYL PALMITATE, DISTEARDIMONIUM HECTORITE, TRIETHOXYCAPRYLYLSILANE, POLYGLYCERYL-4 ISOSTEARATE, HEXYL LAURATE, CETYL PEG/PPG-10/1 DIMETHICONE, LAURETH-7, TRIETHYL CITRATE, PHENOXYETHANOL, METHYLPARABEN [+/-(MAY CONTAIN): MICA, TITANIUM DIOXIDE (CI 77891), IRON OXIDES (CI 77491, CI 77492, CI 77499), BISMUTH OXYCHLORIDE (CI 77163), CHROMIUM OXIDE GREENS (CI 77288)] <ILN28730>
DIST. BY/PAR: MAKE-UP ART COSMETICS
TORONTO, ONTARIO, CANADA M5V 1R7,
LONDON W1K 3BQ. / M49W
| MAC
HYPER REAL SPF 15 FOUNDATION
octinoxate liquid |
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| Labeler - MAKEUP ART COSMETICS (010597206) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| ELGC K.K. | 712808195 | RELABEL(40046-0056), REPACK(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Estee Lauder Pennsylvania Distribution Center 2 (PADC 2) | 828534516 | MANUFACTURE(40046-0056), RELABEL(40046-0056), REPACK(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Estee Lauder Inc. | 042918826 | MANUFACTURE(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| ESTEE LAUDER COSMETICS DISTRIBUTION CENTER | 208579636 | REPACK(40046-0056), RELABEL(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| ESTEE LAUDER COSMETICS, LTD | 253616536 | MANUFACTURE(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| ESTEE LAUDER COSMETICS, LTD | 244669714 | MANUFACTURE(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| ESTEE LAUDER COSMETICS, LTD. | 205952385 | MANUFACTURE(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| ESTEE LAUDER N.V. | 370151326 | MANUFACTURE(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| LEN-RON MANUFACTURING DIVISION OF ARAMIS INC | 809771152 | MANUFACTURE(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| NORTEC KEYSTONE | 943871157 | MANUFACTURE(40046-0056), RELABEL(40046-0056), REPACK(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| NORTHTEC BRISTOL | 959338336 | MANUFACTURE(40046-0056), RELABEL(40046-0056), REPACK(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| NORTHTEC KEYSTONE | 949264774 | MANUFACTURE(40046-0056), RELABEL(40046-0056), REPACK(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| WHITMAN LABORATORIES, LTD. | 216866277 | MANUFACTURE(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Aveda Corporation | 071352058 | MANUFACTURE(40046-0056) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Pennsylvania Logistics Center | 078364654 | REPACK(40046-0056), RELABEL(40046-0056) | |
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.



